
Pharmaceutical Executive · Yesterday · 3 min
Pharmaceutical Executive Daily: 2026 Emerging Pharma Leaders Award Winners Announced
0:00-3:00
transcript
show notes
A funding roundup covers new IPO and Series A raises across Silence Therapeutics, AbCellera, Beyang Therapeutics, and Remepy, Tyler Seville of ADVI examines the policy concerns building around the 340B Drug Pricing Program, and Pharmaceutical Executive names its 2026 Emerging Pharma Leaders.